Evaluation of Moderately Differentiated Adenocarcinoma as a Risk Factor for Lymph Node Metastasis in Colorectal T1 Cancer

Evaluation of Moderately Differentiated Adenocarcinoma as a Risk Factor for Lymph Node Metastasis in Colorectal T1 Cancer - Evaluation of Moderately Differentiated Adenocarcinoma as a Risk Factor for Lymph Node Metastasis in Colorectal T1 Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056905

Enrollment

1300

Registered

2025-02-05

Start date

2024-07-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: T1 CRCs resected between 2001 and 2023 in our hospital.

Exclusion criteria

Exclusion criteria: FAP,Lynch syndrome,Inflammatory bowel disease,Synchronous distant metastasis or advanced CRCs,TEM,Endoscopic resection alone, is excluded.

Design outcomes

Primary

Measure	Time frame
The Rate of Lymph Node Metastasis in T1 Colorectal Cancer.	—

Countries

Japan

Contacts

Public ContactShigenori Semba

Showa University Showa University Northern Yokohama Hospital, Digestive Disease Center

semba@med.showa-u.ac.jp0459497000

Outcome results